Skip to main content
Cancer Explained
Beginner 3 min read

What Is a Blinded Clinical Trial?

A plain-language explanation of blinding — single and double — and why it makes clinical trial results more reliable. Based on the National Cancer Institute.

AI-assisted and source verified. Not reviewed by a healthcare professional unless specifically stated.

Written by: Cancer Explained editorial teamEditorial review: Cancer Explained editorial teamSources last checked: 2026-07-14Last updated: 2026-07-14Next planned review: 2027-07-14

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Our editorial processHow we use AIReport an error

NCI source

National Cancer Institute

The short answer

In a blinded trial, participants (and sometimes the researchers) do not know who is getting which treatment. Blinding reduces bias so results reflect the treatment, not expectations.

  • Blinding means not knowing who receives which treatment.

  • In single-blind trials, participants do not know their group.

  • In double-blind trials, the researchers do not know either.

  • Blinding reduces bias from expectations on both sides.

Choose how you want to understand this

The full explanation.

Not knowing on purpose

In a blinded trial, some of the people involved do not know who is getting which treatment. It sounds strange, but it is done deliberately, and it makes results more trustworthy.

Single and double blind

In a single-blind trial, participants do not know which group they are in. In a double-blind trial, neither the participants nor the researchers working directly with them know until the study is complete. Double-blind designs are considered especially strong.

Why hide it

People's expectations can shape what they notice and report. A patient who knows they are on a promising new drug may feel better simply from hope; a researcher who knows may unconsciously judge results more favorably. Blinding reduces this bias so the findings reflect the treatment, not the expectations.

Safety is protected

Blinding never comes before safety. There is always a way to quickly reveal which treatment a participant received if a medical concern arises. So even in a double-blind trial, the information is available the moment it is needed.

Words to know

Tap any term to see what it means.

Browse the full glossary →

Common questions

What does blinding mean?

Blinding means that some people in a trial do not know who is receiving which treatment. This helps keep expectations from influencing how results are reported or judged.

What is the difference between single and double blind?

In a single-blind trial, participants do not know their group. In a double-blind trial, neither the participants nor the researchers working with them know until the study ends.

Is it safe if my doctor doesn't know?

Yes. There is always a way to quickly find out which treatment a participant received if a safety concern arises. Blinding is never allowed to compromise safety.

Why does blinding matter?

People's expectations — patients' and researchers' — can unconsciously affect results. Blinding reduces that bias so the findings more truly reflect the treatment itself.

Quick quiz

Test your knowledge

0 of 5 answered

  1. Q1.What does blinding mean in a clinical trial?
  2. Q2.In a single-blind trial, who does not know their group?
  3. Q3.In a double-blind trial, who does not know the assignments?
  4. Q4.Why is blinding used?
  5. Q5.Does blinding put safety at risk?

This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.

How this page was created

Cancer Explained uses AI to organize and translate information from the authoritative sources cited on each page. Automated checks review claims, citations, clarity, duplication, and potential safety concerns before publication. Our content is not currently reviewed by physicians unless a specific qualified reviewer is named on the page. Cancer Explained provides general education and should not replace advice from your healthcare team.

Human medical review: not completed. At this time, most Cancer Explained content has not been reviewed by a physician or other healthcare professional. Pages with documented human medical review identify the reviewer, credentials, and review date directly.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.

Related learning map

How this explanation connects to 11 other things you can explore — related topics, terms, questions, practice, and its NCI source.

What Is a Blinded Clinical Trial?